Follow
Interview with Scandion Oncology
08 October 2020 - 11:32
Interview with Scandion Oncology CSO Nils Brünner during the cancer research day at Penser Bank....
Please sign in to view full information or sign up for FREE.
What will You get:
An IPOhub original research paper about TOP10 Nordic IPOs in 2020
Fresh Data, updated daily:
- Active and Upcoming Events - IPO’s, New Share Issues, Exercises, Market moves, Upcoming Listings, Acquisitions.
- Live Press releases (news and media).
- Updates on Your favorite prospects to Your email.
For investment decisions:
- Info on 600+ IPOs, 1400+ listings and 5000+ share issue events.
- Access to database with 3000+ growth companies.
- Data which is collected and brought to You from 100+ sources.
Save time and make better investment decisions with IPOhub. Sign up now until it`s FREE!
Scandion Oncology A/S
Scandion Oncology A/S is a biotechnology company with the mission to address one of the most important challenges in modern oncology - the effective treatment of cancer which has developed resistance towards existing cancer medicine. Its first-in-class lead compound, SCO-101, is an add-on to chemotherapy and is currently in clinical phase I and II studies in cancer patients. The company also has s...
Learn more about company
